DiaMedica Therapeutics (DMAC) Interest Expenses (2017 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Interest Expenses of $23000.0 for Q1 2026, up 2200.0% year-over-year from $1000.0 in Q1 2025, and down 99.91% quarter-over-quarter from $26.5 million in Q4 2025.
DiaMedica Therapeutics (DMAC) Interest Expenses (2017 - 2026) Analysis & Trends
DiaMedica Therapeutics' Interest Expenses history runs 10 years deep, the most recent figure standing at $23000.0 for Q1 2026.
- In Q1 2026, Interest Expenses rose 2200.0% year-over-year to $23000.0; the TTM figure through Mar 2026 stood at $43000.0 (up 115.0% YoY), while the FY2025 annual figure was $42.4 million, up 24.07% from the prior year.
- Interest Expenses for Q1 2026 stood at $23000.0, down from $26.5 million in the prior quarter.
- The five-year high for Interest Expenses was $26.5 million in Q4 2025, with the low at $1000.0 in Q1 2022.
- The 5-year median for Interest Expenses is $832000.0 (2022), against an average of $4.6 million.
- The sharpest annual moves came in 2022 and 2023: Interest Expenses sank 99.98% in 2022, then jumped 11500.0% in 2023.
- DiaMedica Therapeutics' Interest Expenses stood at $832000.0 in 2022, then changed by 0.0% to $832000.0 in 2023, then surged by 1131.13% to $10.2 million in 2024, then soared by 158.51% to $26.5 million in 2025, then slumped by 99.91% to $23000.0 in 2026.
- Business Quant data shows DMAC's Interest Expenses at $23000.0 in Q1 2026, $26.5 million in Q4 2025, and $21.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - | 20.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.26 Mn |
| Jun 30, 2026 | 20.26 Mn |
| Mar 31, 2026 | 23,000.00 |
| Mar 31, 2026 | 23,000.00 |
| Dec 31, 2025 | 26.48 Mn |
| Dec 31, 2025 | 26.48 Mn |
| Sep 30, 2025 | 21.22 Mn |
| Sep 30, 2025 | 21.22 Mn |
| Jun 30, 2025 | 3.77 Mn |
| Jun 30, 2025 | 3.77 Mn |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 10.24 Mn |
| Dec 31, 2024 | 10.24 Mn |
| Sep 30, 2024 | 4.88 Mn |
| Sep 30, 2024 | 4.88 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,000.00 |